- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07826143
Automated vs Manual Polysomnography Scoring in Adults With Obstructive Sleep Apnea
Automated Versus Manual Polysomnographic Scoring in Adult Patients With Obstructive Sleep Apnea: A Prospective Comparative Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Procedures
- Pre-PSG Assessment: Demographic data, anthropometric measurements (weight, height, Body mass index (BMI), neck circumference), vital signs, comorbidities, and the STOP-BANG questionnaire are recorded.
Overnight PSG: Conducted in a sound-attenuated, temperaturecontrolled, well-prepared sleep lab using either SOMNOscreen plus (SOMNOmedics GmbH) or Alice® 6 Sleepware (Philips Respironics, PA,
USA). Both systems acquire this channels montage:
• EEG (six channels: F3, F4, C3, C4, O1, O2 referenced to ipsilateral mastoids)
• EOG (two channels: left and right outer canthus)
• Chin EMG (three channels) and anterior tibialis EMG (two channels, bilateral)
• Airflow (oronasal thermistor + nasal pressure transducer cannula)
• ECG (2 leads)
• Body position sensor
• Snoring microphone
Respiratory inductive plethysmography (RIP) belts for thoracic and abdominal effort (two channels)
• Pulse oximetry (SpO₂, one channel) via finger probe
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Amira Elghonemy, MD candidate
- Phone Number: +201032438035
- Email: amiraelghonemy07@gmail.com
Study Locations
-
-
Cairo Governorate
-
Cairo, Cairo Governorate, Egypt
- Ain Shams University Hospitals
-
Contact:
- Amira Elghonemy, MD candidate
- Phone Number: +201032438035
- Email: amiraelghonemy07@gmail.com
-
Principal Investigator:
- Amira Elghonemy, MD candidate
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age > 18 years. • Clinical suspicion of OSA based on history, physical examination, and a positive screening questionnaire (e.g., STOP-BANG ≥ 3).
Ability to provide written informed consent.
Exclusion Criteria:
- Age ≤ 18 years. • Inability to give informed consent (e.g., severe cognitive impairment, language barrier). • Contraindications to PSG (e.g., severe skin conditions preventing electrode placement).
Current use of therapies that could alter sleep architecture (e.g., highdose benzodiazepines, opioids) unless a wash-out period is observed.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adult OSA Patients
Adult patients diagnosed with Obstructive Sleep Apnea undergoing polysomnography to compare automated versus manual scoring.
|
Comparison between automated scoring software and standard manual scoring by expert specialists for sleep study records.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Apnea-Hypopnea Index (AHI) Agreement
Time Frame: At the time of sleep study completion (1 night)
|
Comparison of the Apnea-Hypopnea Index (AHI) values obtained from automated polysomnographic scoring against those obtained from manual scoring.
|
At the time of sleep study completion (1 night)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Amira Elghonemy, MD candidate, Ain shams university
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU MD 129/2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.